Overview

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Status:
Unknown status
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to determine whether Tacrolimus and Prednisolone are effective and safe in the treatment of the cyclophosphamide-resistant, refractory diffuse proliferative lupus nephritis
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Tacrolimus